Nuance Investments LLC acquired a new stake in Globe Life Inc. (NYSE:GL - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 10,760 shares of the company's stock, valued at approximately $1,923,000.
Other large investors have also modified their holdings of the company. MidFirst Bank purchased a new position in Globe Life in the second quarter worth $563,000. BlackRock Inc. purchased a new stake in shares of Globe Life in the second quarter valued at about $987,901,000. Objectivity Squared LLC purchased a new stake in Globe Life in the 2nd quarter valued at approximately $242,000. Pallas Capital Advisors LLC purchased a new stake in shares of Globe Life in the second quarter valued at $1,801,000. Finally, Deutsche Bank AG acquired a new position in Globe Life in the 2nd quarter valued at $34,702,000. 81.61% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other news, EVP Michael Clay Majors sold 37,000 shares of Globe Life stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the transaction, the executive vice president owned 53,518 shares of the company's stock, valued at $9,560,455.52. The trade was a 40.88% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, CFO Thomas Peter Kalmbach sold 25,650 shares of Globe Life stock in a transaction that occurred on Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total transaction of $4,580,577.00. Following the completion of the transaction, the chief financial officer owned 50,568 shares in the company, valued at approximately $9,030,433.44. This trade represents a 33.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 179,844 shares of company stock worth $31,616,279 in the last quarter. 2.11% of the stock is currently owned by corporate insiders.
Globe Life Trading Down 0.6%
Globe Life stock opened at $180.00 on Tuesday. Globe Life Inc. has a 52-week low of $127.85 and a 52-week high of $191.55. The firm has a market capitalization of $13.83 billion, a price-to-earnings ratio of 11.95 and a beta of 0.48. The firm has a 50-day moving average price of $177.61 and a two-hundred day moving average price of $157.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43.
Globe Life (NYSE:GL - Get Free Report) last posted its earnings results on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.52%. The business had revenue of $1.60 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter in the prior year, the business earned $3.05 earnings per share. The firm's revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. Sell-side analysts expect that Globe Life Inc. will post 15.71 earnings per share for the current year.
Globe Life announced that its board has initiated a share buyback plan on Monday, August 10th that permits the company to buyback $2.50 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 17.7% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board of directors believes its shares are undervalued.
Globe Life Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Monday, October 5th will be issued a $0.33 dividend. The ex-dividend date is Monday, October 5th. This represents a $1.32 annualized dividend and a dividend yield of 0.7%. Globe Life's dividend payout ratio (DPR) is 8.76%.
Wall Street Analysts Forecast Growth
Several research firms have commented on GL. Weiss Ratings cut Globe Life from a "buy (b)" rating to a "buy (b-)" rating in a report on Monday, July 20th. JPMorgan Chase & Co. increased their price target on Globe Life from $181.00 to $201.00 and gave the company an "overweight" rating in a report on Tuesday, July 21st. Keefe, Bruyette & Woods dropped their price objective on shares of Globe Life from $192.00 to $190.00 and set an "outperform" rating on the stock in a research note on Friday, July 24th. TD Cowen lifted their target price on Globe Life from $215.00 to $225.00 and gave the stock a "buy" rating in a research report on Wednesday, July 22nd. Finally, Truist Financial increased their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a "buy" rating in a research note on Friday, April 24th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $191.67.
Get Our Latest Research Report on Globe Life
Globe Life Profile
(
Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report